Continuous Bioprocessing Market Is Driving By Real-time Product Quality Monitoring

By Author: colin
Total Articles: 166
Comment this article

Continuous bioprocessing is a production method that eliminates batch operations and enables a seamless production flow. It provides significant advantages over conventional batch manufacturing including greater productivity, improved process control and increased product quality consistency. Continuous bioprocessing allows biopharmaceutical companies to produce multiple products simultaneously and facilitate real-time quality monitoring through inline sensing and process analytical technology. This allows timely decisions for process adjustment and intervention if needed.

The Continuous Bioprocessing market is estimated to be valued at US$ 395 Mn in 2024 and is expected to exhibit a CAGR of 8.4% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the Continuous Bioprocessing market include AGC Biologics, Biogen, Bristol-Myers Squibb, Sanofi Genzyme, FUJIFILM Diosynth Biotechnologies and others. The key players are focusing on capacity expansion and technological advancements to meet the growing demand.

The global demand for biologics has been increasing rapidly which is driving ...
... the need for continuous manufacturing to support production at large scale in a cost effective manner. Many biopharma companies are implementing continuous bioprocessing for commercial production of biologics.

Many companies are expanding their manufacturing facilities globally especially in Asia Pacific and Europe to establish regional supply networks and be closer to market demand. This is expected to support the growth of continuous bioprocessing market.

Market Drivers

The major factor fueling the growth of continuous bioprocessing market is the significant advantages it provides over conventional batch processing such as higher productivity, improved process understanding, better product quality consistency and lesser work in process inventory. Continuous bioprocessing allows 10 to 100 fold higher annual production levels compared to batch mode. This has increased its adoption especially for large volume commercial production of biologics. Moreover, the capability of continuous bioprocessing to facilitate real-time monitoring and process adjustment is further driving its demand from biopharma industry.

The Impact Of Current Geopolitical Situation On Continuous Bioprocessing Market Growth

The continuous bioprocessing market is witnessing steady growth over the past few years. However, the ongoing geopolitical tensions and conflicts among various countries pose certain challenges for the overall market expansion. Regional disputes and sanctions imposed by major economies are negatively impacting international trades and collaborations. This is hindering seamless knowledge and technology sharing among biopharmaceutical manufacturers across borders. Additionally, volatile crude oil prices and supply chain disruptions caused due to geopolitical issues raise production costs. It also affects the stable procurement of critical raw materials for continuous bioprocessing.

To sustain momentum, market players must focus on strategic partnerships within regions to minimize dependencies on global supply chains. Localized manufacturing through joint ventures can help to circumvent trade barriers. Collaborations with local research institutes and startups will aid technology transfer. Government incentives and funding support for indigenous R&D activities can accelerate new product development. Overall, the continuous bioprocessing market has significant growth prospects if manufacturers proactively address geopolitical challenges through self-reliance, regionalization, and collaborative innovation.

Concentration Of Continuous Bioprocessing Market By Geographical Regions

In terms of value, the continuous bioprocessing market is currently concentrated highly in North America and Europe. The developed markets in these regions accounted for over 60% of the global market share in 2024 led by a strong biopharmaceutical industry presence and availability of advanced healthcare infrastructure. Increased translation research and widespread adoption of continuous technologies by major drug makers sustain high demand. Asia Pacific is emerging as the fastest-growing regional market and expected to witness a CAGR of 12.5% during the forecast period. Considerable investments in building new biomanufacturing facilities, favorable regulatory environment, and growing contract services offer immense opportunities.

Fastest Growing Region In Continuous Bioprocessing Market

Asia Pacific region represents the most lucrative market for continuous bioprocessing and is expected to exhibit the highest growth rate during the forecast period from 2024 to 2031. The biologics market in Asia is growing at a rapid pace owing to increasing prevalence of chronic diseases, rising healthcare spending, and strong government support for pharmaceutical R&D. Major global pharmaceutical companies have established production plants in China, India, Singapore, and South Korea to serve Asian markets as well as export to other regions. Investments in continuous manufacturing technologies are rising led by technological innovations. The growing CRAM industry in countries like China and India provides significant impetus. Favorable regulatory guidelines further propel adoption. These factors will significantly drive the continuous bioprocessing market growth in Asia Pacific.

Get more insights on this topic: https://www.zupyak.com/p/4269087/t/continuous-bioprocessing-market-set-for-rapid-growth-due-to-wide-adoption-across-pharmaceutical-industry

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

What Are The Key Data Covered In This Continuous Bioprocessing Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Continuous Bioprocessing's growth between 2024 and 2031.

:- Accurate calculation of the size of the Continuous Bioprocessing and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Continuous Bioprocessing Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Continuous Bioprocessing vendors

FAQ’s

Q.1 What are the main factors influencing the Continuous Bioprocessing?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Continuous Bioprocessing companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Continuous Bioprocessing’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it